- CIIX recently hired Boustead Securities LLC as underwriter for the planned IPO of its wholly owned subsidiary, CBD Biotech
- Warren Wang, CEO of CIIX, said that the move is part of its strategic plan, as CIIX looks to return to its root activities in education and consulting with companies seeking to raise profile within the investment community
- Boustead Securities would serve as IPO sponsor and underwriter, CIIX said
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) retention of Boustead Securities LLC for its anticipated IPO of wholly owned foreign enterprise CBD Biotech will enable the company to focus on its revenue base in video and online education, investor relations services and subscription activities. At the same time, CIIX plans to secure a separate exchange listing for CBD Biotech (http://cnw.fm/ryVA6).
In a news release, Warren Wang, CEO of CIIX, said, “Additionally, we believe that listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.”
Dan McClory, Boustead Securities’ managing director, head of China and head of equity capital markets, was optimistic. “We believe CBD Biotech can potentially gain a first mover advantage in the Chinese CBD market and could be well received in the public markets,” he noted in a news release.
CIIX sees CBD Biotech delivering higher CBD product distribution in FY2019, both domestically and in China. It reported an 800 percent increase in product sales led by ChineseHempOil.com, Inc. during its fiscal first quarter of 2019. CIIX recorded 70 percent higher YOY sales for the same fiscal quarter (http://cnw.fm/sM3Fs).
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
CannabisNewsWire is at the epicenter of the Cannabis Revolution.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com